Ads
related to: weight loss, experimental drugs
Search results
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 5 days agoA deputy was calling with good news: The company’s new, experimental drug tirzepatide not only cut...
Gateway - Quartz
Quartz· 8 hours agoDenmark’s prime minister, Mette Frederiksen, called the Ozempic “fantastic” and said she was “huge fan” at a parliamentary debate. People who depend on daily insulin shots may soon have welcome ...
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity ...
Motley Fool via Yahoo Finance· 4 days ago/Mounjaro could achieve greater weight loss. This efficacy advantage could enable Lilly's weight-...
Guidelines outline nutrition requirements for those on Ozempic, Wegovy, Zepbound
UPI· 7 days agoFolks using a weight-loss drugs like Ozempic, Wegovy or Zepbound still have nutritional requirements...
Flagship taps startup to hunt for obesity drugs that might interest Pfizer
BioPharma Dive via Yahoo Finance· 6 days agoThe venture firm will work with ProFound Therapeutics to “rapidly surface” protein drug candidates...
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It
Motley Fool via Yahoo Finance· 3 days agoIt was a phase-one trial but an encouraging one nonetheless. AstraZeneca has shown interest in the...
Merck pursuing next-generation opportunities in cardiometabolic drugs
Reuters via AOL· 7 days ago(Reuters) -Merck is focused on second- and third-generation opportunities in the cardiometabolic...
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Motley Fool via Yahoo Finance· 3 days agoAlpine's porvetacicept should advance into phase 3 testing for treating the rare kidney disease IgA...
Takeda drug for rare types of epilepsy misses goal in late-stage trial
BioPharma Dive via Yahoo Finance· 1 day agoCalled soticlestat, the drug had seemed promising in earlier studies for people with Dravet and...
3 Stocks That Have Soared 179% or More in 2024 and Could Go Even Higher, According to Wall Street
Motley Fool via Yahoo Finance· 1 day agoThe biggest story for Viking was its announcement in late February of results from a phase 2 study...
Ads
related to: weight loss, experimental drugs
